Bio-Techne Corp (NAS:TECH)
$ 83.805 0.965 (1.16%) Market Cap: 13.21 Bil Enterprise Value: 13.40 Bil PE Ratio: 66.51 PB Ratio: 6.55 GF Score: 92/100

Bio-Techne Corp at Stephens NASH Investment Conference (Virtual) Transcript

Nov 17, 2020 / 08:00PM GMT
Release Date Price: $76.93 (+1.61%)
Jacob K. Johnson
Stephens Inc., Research Division - Analyst

All right. Good afternoon, everybody. I'm Jacob Johnson, the life science tools and diagnostics analyst here at Stephens. Welcome to day 2 of the Stephens Conference. Happy to be joined by the Bio-Techne team this afternoon. We got CEO, Chuck Kummeth; CFO, Jim Hippel; along with Dave Clair, Senior Director of IR and Corporate Development.

(Operator Instructions)

With that out of the way, Chuck, maybe to kick things off, if you just want to give a brief overview of the Bio-Techne story, and then we'll jump into Q&A.

Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director

Sure. Well, I just had my 30th earnings call, so it's been 7.5 years. Jim is here on the call with me, he's close behind me at -- going on 7 years. Dave just joined a year ago, but he's been working with us for at least 3, if not 4. And been a big help, by the way.

We are a reagents, tools -- reagents and tools company for life sciences industry. We have a lot of products. We're very

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot